Cost effectiveness of pneumococcal vaccination among Dutch infants; economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines

M.H. Rozenbaum; E.A.M. Sanders; A.J. Hoek van; A.G.S.C. Jansen; A. van der Ende; G.P.J.M. van der Dobbelsteen; G.D. Rodenburg; E. Hak; M.J. Postma

Cost effectiveness of pneumococcal vaccination among Dutch infants; economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines

Translated title of the contribution: Cost effectiveness of pneumococcal vaccination among Dutch infants; economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines

M.H. Rozenbaum, E.A.M. Sanders, A.J. Hoek van, A.G.S.C. Jansen, A. van der Ende, G.P.J.M. van der Dobbelsteen, G.D. Rodenburg, E. Hak, M.J. Postma

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Cost effectiveness of pneumococcal vaccination among Dutch infants; economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines
Original language	Undefined/Unknown
Pages (from-to)	c2509
Number of pages	1
Journal	BMJ (International edition)
Volume	340
Publication status	Published - 2010

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/20519267

Cite this

Rozenbaum, M. H., Sanders, E. A. M., Hoek van, A. J., Jansen, A. G. S. C., van der Ende, A., van der Dobbelsteen, G. P. J. M., Rodenburg, G. D., Hak, E., & Postma, M. J. (2010). Cost effectiveness of pneumococcal vaccination among Dutch infants; economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines. BMJ (International edition), 340, c2509. http://www.ncbi.nlm.nih.gov/pubmed/20519267

@article{de3dee3270894c48b1dbb394dfc1631a,

title = "Cost effectiveness of pneumococcal vaccination among Dutch infants; economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines",

author = "M.H. Rozenbaum and E.A.M. Sanders and {Hoek van}, A.J. and A.G.S.C. Jansen and {van der Ende}, A. and {van der Dobbelsteen}, G.P.J.M. and G.D. Rodenburg and E. Hak and M.J. Postma",

note = "free article",

year = "2010",

language = "Undefined/Unknown",

volume = "340",

pages = "c2509",

journal = "BMJ (International edition)",

issn = "0959-535X",

}

Rozenbaum, MH, Sanders, EAM, Hoek van, AJ, Jansen, AGSC, van der Ende, A, van der Dobbelsteen, GPJM, Rodenburg, GD, Hak, E & Postma, MJ 2010, 'Cost effectiveness of pneumococcal vaccination among Dutch infants; economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines', BMJ (International edition), vol. 340, pp. c2509. <http://www.ncbi.nlm.nih.gov/pubmed/20519267>

Cost effectiveness of pneumococcal vaccination among Dutch infants; economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines. / Rozenbaum, M.H.; Sanders, E.A.M.; Hoek van, A.J. et al.
In: BMJ (International edition), Vol. 340, 2010, p. c2509.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Cost effectiveness of pneumococcal vaccination among Dutch infants; economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines

AU - Rozenbaum, M.H.

AU - Sanders, E.A.M.

AU - Hoek van, A.J.

AU - Jansen, A.G.S.C.

AU - van der Ende, A.

AU - van der Dobbelsteen, G.P.J.M.

AU - Rodenburg, G.D.

AU - Hak, E.

AU - Postma, M.J.

N1 - free article

PY - 2010

Y1 - 2010

M3 - Article

SN - 0959-535X

VL - 340

SP - c2509

JO - BMJ (International edition)

JF - BMJ (International edition)

ER -